The FDA's acceptance of the sNDA triggers a milestone payment to Medivation under its collaboration agreement with Astellas.About the PREVAIL TrialThe Phase 3 PREVAIL trial is a randomized, double-blind, placebo-controlled, multi-national trial that enrolled more than 1,700 patients at sites in the United States, Canada, Europe, Australia, Russia, Israel and Asian countries including Japan.